Clinical Trial Update: Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of pazopanib with paclitaxel in advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Taxol (paclitaxel)
• Votrient (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 1 | Status: COMPLETED